Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Jeremy Max Levin
Age : 66
Public asset : 16,845,125 USD
Linked companies : H. Lundbeck A/S - Opthea Limited - Ovid Therapeutics Inc.
Jeremy Max Levin is a businessperson who has been at the head of 9 different companies and presently occupies the position of Chairman, President & Chief Executive Officer for Ovid Therapeutics, Inc., Chairman of Opthea Ltd. and President & Director at Medarex, Inc. Dr. Levin is also on the board of H. Lundbeck A.

In the past he occupied the position of President & Chief Executive Officer of Teva Pharmaceutical Industries Ltd. and President & Chief Executive Officer for Teva Pharmaceuticals Ltd. (a subsidiary of Teva Pharmaceutical Industries Ltd.), SVP-Strategy, Alliances & Transactions at Bristol Myers Squibb Co. and President & Director at ZymoGenetics, Inc. (a subsidiary of Bristol Myers Squibb Co.), Chairman & Chief Executive Officer at Cadus Corp., Chief Executive Officer for Physiome Sciences, Inc., Global Head-Strategic Alliances at Novartis Institutes for Biomedical Research, Inc. and Chairman for Biotechnology Innovation Organization.

He received a doctorate from the University of Cambridge and an undergraduate degree, a graduate degree and a doctorate from the University of Oxford.

Current positions of Jeremy Max Levin 
NameTitle Since
H. Lundbeck A/S
Director 2017
Opthea Limited
(Biotechnology & Medical Research)
Chairman 2020
Ovid Therapeutics Inc.
(Biotechnology & Medical Research)
Chairman, President & Chief Executive Officer 2021
Medarex, Inc. President & Director 2011

Holdings of Jeremy Max Levin 
Ovid Therapeutics Inc. (OVID)
(Biotechnology & Medical Research)
4,771,9907.02%16,845,125 USD
Opthea Limited (OPT)
(Biotechnology & Medical Research)
00.0000%0 USD

Jeremy Max Levin: Personal Network 
Most Read News 
09/22WILLIAM ACKMAN : Ackman's Pershing Square fund surges as Universal soars in stock debut
09/24CATHIE WOOD : Chinese crackdown on bitcoin another blow to Cathie Wood's ARK ETF
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
09/24ELON MUSK : New semiconductor plants will end global auto chip shortage next year -Tesla's Musk
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
09/22CATHIE WOOD : ARK's Cathie Wood says Wall Street not in a bubble
09/21JEFF BEZOS : UK's Johnson discussed taxation with Amazon's Bezos
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
09/24BARRY DILLER : Stock Futures Weaken After Evergrande Payment Deadline Passes
09/15JARED ISAACMAN : Stock Futures Tick Up After Market Pullback
More news

© 2021 People and Ownership :   
Jeremy Max Levin : Connections